| 000 | 01669 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514051654.0 | ||
| 264 | 0 | _c20021209 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/01.wnl.0000036271.49066.06 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFisher, E | |
| 245 | 0 | 0 |
_aEight-year follow-up study of brain atrophy in patients with MS. _h[electronic resource] |
| 260 |
_bNeurology _cNov 2002 |
||
| 300 |
_a1412-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAtrophy |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 |
_aInterferon-beta _xadministration & dosage |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 700 | 1 | _aRudick, R A | |
| 700 | 1 | _aSimon, J H | |
| 700 | 1 | _aCutter, G | |
| 700 | 1 | _aBaier, M | |
| 700 | 1 | _aLee, J-C | |
| 700 | 1 | _aMiller, D | |
| 700 | 1 | _aWeinstock-Guttman, B | |
| 700 | 1 | _aMass, M K | |
| 700 | 1 | _aDougherty, D S | |
| 700 | 1 | _aSimonian, N A | |
| 773 | 0 |
_tNeurology _gvol. 59 _gno. 9 _gp. 1412-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.wnl.0000036271.49066.06 _zAvailable from publisher's website |
| 999 |
_c12235048 _d12235048 |
||